Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Management Strategy for NSTEMI Based on TIMI Risk Score

Risk Stratification and Management

  • The American College of Cardiology recommends that high-risk NSTEMI patients (TIMI score >4) receive an early invasive strategy within 24 hours of admission to reduce mortality and recurrent cardiovascular events 1, 2
  • Immediate invasive strategy is indicated for patients with refractory angina, signs/symptoms of heart failure, hemodynamic instability, recurrent angina/ischemia, or sustained ventricular tachycardia/ventricular fibrillation 4
  • Early invasive strategy is indicated for high-risk patients with a TIMI risk score >4, GRACE risk score >140, temporal change in troponin, or new ST depression 1, 2, 4
  • Delayed invasive strategy is indicated for intermediate-risk patients with a TIMI risk score of 2-4, GRACE risk score 109-140, diabetes mellitus, renal insufficiency, reduced LV systolic function, early post-infarction angina, or prior CABG 2, 4

Pharmacological Management

  • Aspirin should be administered at a loading dose of 81-325 mg, followed by a daily dose of 81-325 mg indefinitely 4
  • A P2Y12 inhibitor loading dose should be given before PCI with stenting, with options including clopidogrel 600 mg, prasugrel 60 mg, or ticagrelor 180 mg 4
  • Dual antiplatelet therapy should be continued for at least 12 months after stent placement 4
  • Unfractionated heparin or low molecular weight heparin should be administered, with consideration of glycoprotein IIb/IIIa inhibitors in high-risk patients 4, 5, 6

Special Considerations

  • Elderly patients (≥75 years) should undergo individualized risk assessment using both TIMI and GRACE risk scores, and prasugrel is generally not recommended due to increased bleeding risk 3, 7
  • Contraindications to invasive strategy include extensive comorbidities and low likelihood of ACS with negative troponins 4

Prognostic Value of TIMI Risk Score

  • The risk of adverse outcomes increases with higher TIMI scores, with a score of 0-1 indicating a ~5% risk of death, MI, or urgent revascularization, and a score of 6-7 indicating a ~41% risk 5

Common Pitfalls to Avoid

  • Delaying invasive strategy in high-risk patients (TIMI >4) beyond 24 hours, failing to use validated risk scores, underestimating risk in patients with renal dysfunction, and not considering multiple biomarkers for comprehensive risk assessment should be avoided 1, 2, 3, 5

REFERENCES